Tuesday, December 5, 2023

DGCI panel approve Covovax EUA for 7-11 age group: Source


Share post:

New Delhi, June 25:  Drugs Controller General of (DCGI) India on Friday recommended Emergency Use Authorisation (EUA) for Serum Institute of India’s Covovax vaccine for children aged 7-11, a source on Friday.

“The Subject Expert Committee of Drugs Controller General Of India has recommended Serum Institute of India’s (SII) vaccine Covovax for children in the age group of 7-11 years,” said the source.

The expert panel recommendation has been sent to the DCGI for final approval.

However, DGCI will review the recommendation before nodding for final approval. The expert panel in its last meeting in April had sought more information from Serum Institute over the application, as per the source.

India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, and in the 12-17 age group with certain conditions on March 9.


Related articles

Meghalaya Speaker inspects new Assembly building at Mawdiangdiang

Shillong, Dec 5:  The Speaker of the Meghalaya Legislative Assembly, Thomas A Sangma, conducted an inspection and chaired...

3rd Meghalaya Games will be confluence of modern, traditional games

Shillong, Dec 5: The third edition of the Meghalaya Games in Tura will be unlike the first two...

‘Recovering addicts require empathy to get out of the tunnel’

Shillong, Dec 5: "If Alexander the Great and Hitler could not achieve anything by brute force, how can...

Highest use of tobacco amongst school children in Meghalaya

  Shillong, Dec 5: The use of tobacco is highest at 96.4 percent among school children in Meghalaya, followed...